Search Results

You are looking at 1 - 10 of 38 items for :

  • "hypertrophic cardiomyopathy" x
  • Refine by Access: All content x
Clear All
Open access

Antonis Pantazis, Annina S Vischer, Maria Carrillo Perez-Tome, and Silvia Castelletti

Introduction Hypertrophic cardiomyopathy (HCM) is an inherited heart disease defined by increased left ventricular (LV) wall thickness (≥15 mm in one or more LV myocardial segments), that cannot be explained by abnormal loading conditions (1) . It

Open access

Neil Howell and William Bradlow

Historical perspective Soon after left ventricular outflow tract obstruction (LVOTO) was first described in individuals with hypertrophic cardiomyopathy (HCM), it was posited that it was primarily due to the physical obstructive effects of the

Open access

Lauren Turvey, Daniel X Augustine, Shaun Robinson, David Oxborough, Martin Stout, Nicola Smith, Allan Harkness, Lynne Williams, Richard P Steeds, and William Bradlow

Intent behind update These guidelines on hypertrophic cardiomyopathy (HCM) represent a six-year update ( 1 ). They contain a description of pertinent disease features and the critical echo parameters needed to evaluate the condition, alongside

Open access

Nicola Smith, Richard Steeds, Navroz Masani, Julie Sandoval, Gill Wharton, Jane Allen, John Chambers, Richard Jones, Guy Lloyd, Bushra Rana, Kevin O'Gallagher, Richard Wheeler, and Vishal Sharma

dataset required in patients either being assessed for, or with a known diagnosis of hypertrophic cardiomyopathy (HCM). The views and measurements are supplementary to those outlined in the minimum dataset and are given assuming that a full study will be

Open access

Natesa G Pandian, Ethan J Rowin, Ana Maria Gonzalez Gonzalez, and Martin S Maron

Introduction Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease with enormous diversity in phenotype expression (1) . The classic description of HCM is that of hypertrophy of the basal anterior septum, systolic anterior

Open access

Umut Kocabas, Esra Kaya, and Cahide Soydas Cinar

hypertrophic cardiomyopathy . Echo Research and Practice 1 45 – 53 . ( doi:10.1530/erp-15-0007 ) 2 Kumar V Yoshida N Yamada T 2015 Successful implantable cardioverter-defibrillator implantation through a communicating branch of the

Open access

Sergio Barros-Gomes, Niyada Naksuk, Dragan Jevremovic, and Hector R Villarraga

presentation A 49-year-old male was referred to Mayo Clinic for diagnostic evaluation of hypertrophic cardiomyopathy (HCM) based on an ECG 1 year earlier presented with 8 weeks of a periorbital rash. An ECG from that time noted concentric LV wall thickening

Open access

Adrian Chenzbraun

Valvular heart disease Hypertrophic cardiomyopathy Dilated cardiomyopathy Diastolic dysfunction Pulmonary hypertension SE beyond diagnosis of myocardial ischaemia The use of SE for non-CAD conditions focuses on the

Open access

H C Sinclair, P Russhard, C H Critoph, and C D Steadman

Background The 2015 European Society of Cardiology (ESC) guidelines recommend provocation testing to assess for latent LVOT obstruction in all patients with exertional symptoms who have either hypertrophic cardiomyopathy (HCM) or isolated

Open access

Robert M Cooper, Adeel Shahzad, and Rodney H Stables

Background Hypertrophic cardiomyopathy (HCM) is an inherited disease characterised by otherwise unexplained hypertrophy of the myocardium. It is transmitted in an autosomal dominant pattern with variable penetrance, with an estimated phenotypic